Viewing Study NCT03876769


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2026-02-20 @ 5:42 AM
Study NCT ID: NCT03876769
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-23
First Post: 2018-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module